Sabah Tuzun

Dr. Sabah Tuzun

orcid

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 November 2018 in Turkish Journal of Gastroenterology
Verified
Journal Article
Closed access
GŞGülcan Şahin-Eryılmaz
Gülcan Şahin-Eryılmaz
KBKayhan Basak
Kayhan Basak
ÖÇÖzlem Çakır-Madenci
Özlem Çakır-Madenci
HKHacer Koç
Hacer Koç
STSabah Tuzun
Sabah Tuzun
MDMustafa Reşat Dabak
Mustafa Reşat Dabak
Background/Aims: This study aimed to evaluate the relationship between irritable bowel syndrome (IBS) and plasma and tissue ghrelin levels. Materials and Methods: Patients who had undergone gastroscopy procedure for any reason previously were enrolled in the study. Among these, patients with IBS symptoms were evaluated according to the Roma III criteria. The healthy control group comprised patients with no IBS symptom and had undergone gastroscopy procedure for another reason. The plasma ghrelin level and tissue ghrelin level obtained by immunohistochemical examination of biopsy specimens taken from the gastric antrum and corpus were evaluated in all participants. Results: The mean age of 90 participants was 43.64±12.64 years. The median value of the plasma ghrelin level was 3.29 (1.2-12.7) in the diarrhea group (IBS-D), 1.49 (0.82-7.08) in the constipation group (IBS-C), and 1.5 (0.2-3.7) in the control group. The plasma ghrelin levels between the groups were found to be significantly higher in IBS-D than in IBS-C and the control groups (p=0.001 and p=0.001, respectively). On comparing antral mucosal gland biopsy outcomes among the groups, staining intensity score was found to be significantly high in IBS-C as compared with the control group, whereas no significant difference was observed between IBS-D and the control groups (p=0.020 and p=0.429, respectively). Conclusion: The plasma ghrelin level in IBS-D and the staining intensity in the antral mucosal gland in IBS-C were found to be significantly higher. In addition, there was no difference between the groups in terms of ghrelin staining intensity in the gastric corpus. Cite this article as: Şahin-Eryılmaz G, Başak K, Çakır-Madenci Ö, et al. Relationship between irritable bowel syndrome and plasma and tissue ghrelin levels. Turk J Gastroenterol 2018; 29: 631-5.

15 May 2019 in Diabetes & Metabolic Syndrome: Clinical Research & Reviews
Verified
Journal Article
Closed access
MDMustafa Reşat Dabak
Mustafa Reşat Dabak
ESElif Sevinç
Elif Sevinç
STSabah Tuzun
Sabah Tuzun
EGEmine Özel Gün
Emine Özel Gün

1 August 2018 in Journal of the College of Physicians and Surgeons Pakistan
Verified
Journal Article
Closed access
STSabah Tuzun
Sabah Tuzun
SCSerap Cifcili
Serap Cifcili
MDM. Resat Dabak
M. Resat Dabak
ITIsmet Tamer
Ismet Tamer
MSMehmet Sargin
Mehmet Sargin
Objective: To assess the frequency of sarcopema in type 2 diabetes mellitus (DM) patients using different formulas of bioimpedance analysis (BIA) Study Design: Cross-sectional study. Place and Duration of Study: Obesity Clinic, Kartal Dr. Lutfi Kirdar Training and Research Hospital, Istanbul, Turkey, between March and June 2015. Methodology: The present study included DM patients at >= 18 years of age with BMI >= 30 kg/m(2). BIA measurements consisted of body weight, height, total muscle mass and sum of the muscle masses of the four limbs (ALM). Skeletal muscle index, total muscle index, skeletal muscle percentage, total muscle percentage, and ALM/BMI were used for muscle-related analyses. The data were presented as frequency, mean +/- standard deviation, and percentage Student t-test was used to compare differences between two independent groups. Results: A total of 295 DM patients were enrolled in the study, of whom 176 (59.66%) were females, 119 (40.34%) were males, 47 (15.93%) were over the age of 65 years, and the mean age was 53.39 +/- 10.39 years. Sarcopenia was determined in 40 males (33.61%) by body muscle ratio, in 15 males (12.60%) by ALM/BMI ratio, and in one male participant (0.84%) by skeletal muscle index. Among female participants, while sarcopenia was determined in 61 (34.65%) by body muscle ratio and in 1 (0.56%) by ALM/BMI ratio, no sarcopenia case was detected using skeletal muscle index. Conclusion: The frequency of sarcopenia in obese diabetic patients is found to be lower when skeletal muscle index and ALM/BMI ratio is used, but higher with body muscle ratio.

19 February 2024 in Scientific Reports
Verified
Journal Article
Open access
PDF file
CÖCan Öner
Can Öner
BDBurcu Dogan
Burcu Dogan
STSabah Tuzun
Sabah Tuzun
AEAsiye Ekinci
Asiye Ekinci
GFGunes Feyizoglu
Gunes Feyizoglu
BBBanu Isbilen Basok
Banu Isbilen Basok
Diabetic retinopathy is a commonly observed cause of blindness and is a common problem in individuals with diabetes. Recent investigations have showed the capability of serum α-Klotho and FGF 23 in mitigating the effects of diabetic retinopathy. This study aimed to discover the correlation between FGF 23, α-Klotho, and diabetic retinopathy in type 1 diabetics. This case–control study included 63 diabetic patients and 66 healthy controls. Following an overnight duration of fasting, morning blood samples were taken from both the patient and the control groups. The serum concentrations of α-Klotho and FGF 23 were quantified. An experienced ophthalmologist inspected the retinopathy. All participants in this study have moderate non-proliferative retinopathy. A p value under 0.05 was considered statistically significant. The mean α-Klotho level for retinopathic diabetic patients was 501.7 ± 172.2 pg/mL and 579.6 ± 312.1 pg/mL for non-retinopathic diabetic patients. In comparison, α-Klotho level of the control group was 523.2 ± 265.4 pg/mL (p = 0.531). The mean of FGF 23 level did not demonstrate a significant difference (p = 0.259). The mean FGF 23 level were 75.7 ± 14.0 pg/mL, 74.0 ± 14.8 pg/mL and 79.3 ± 14.4 pg/mL in groups, respectively. In conclusion, there was no significant difference in FGF 23 and α-Klotho levels between type 1 diabetics with and without retinopathy when compared to the control group.

1 November 2017
Verified
Journal Article
Closed access
STSabah Tuzun
Sabah Tuzun
CÖCan Öner
Can Öner
MDM. Resat Dabak
M. Resat Dabak
HKHalim Omer Kasikci
Halim Omer Kasikci
MSMehmet Sargin
Mehmet Sargin

23 June 2017 in Ankara Medical Journal
Verified
Journal Article
Open access
EOEkrem Orbay
Ekrem Orbay
STSabah Tuzun
Sabah Tuzun
BÇBerfu Çınkıt
Berfu Çınkıt
MÖMuhammed Burak Ölmez
Muhammed Burak Ölmez
STSinem Tekin
Sinem Tekin
MSMehmet Sargın
Mehmet Sargın
Amaç: Gestasyonel diabetes mellitus (GDM) tüm dünyada giderek artan sıklıkla görülmektedir. Bazı çalışmalarda GDM olan gebelerde anksiyete ve depresyon sıklığının olmayanlara göre daha fazla olduğu saptanmıştır. Bu çalışmada GDM’nin gebelerde anksiyete düzeyinde artışa neden olup olmadığının saptanması amaçlanmıştır. Materyal ve Metot: Bu kesitsel çalışma Kartal Dr. Lütfi Kırdar Eğitim ve Araştırma Hastanesi Kadın Hastalıkları ve Doğum Kliniği’ne Haziran 2014 - Haziran 2015 tarihleri arasında başvuran ve 75 gram oral glikoz yükleme testi sonucunda GDM saptanan ve saptanmayan 281 gebede yapılmıştır. Tüm gebelere araştırmacılar tarafından oluşturulan bir anket formu ve Hastane Anksiyete ve Depresyon (HAD) Ölçeği uygulanmıştır. Bulgular: Çalışmaya toplamda 281 gebe dahil edilmiş olup, 133 (%47,33)’ü sağlıklı gebe iken 148 (%52,67)’ı gestasyonel diyabet tanısı almıştır. Katılımcıların yaş ortalaması 30,17 ± 5,62 yıl, gebelik süresi 202,71 ± 56,31 gün idi. Eğitim durumlarına göre katılımcıların 178 (%66,90)’i ilkokul mezunuydu. Gebelerin anksiyete alt ölçek puan ortalaması 9,16 ± 2,88 ve depresyon alt ölçek puan ortalaması 9,05 ± 2,42 olarak saptandı. Tüm gebelerin 108 (%40,30)’inde anksiyete alt ölçek puanı 10 ve üzerinde saptanırken, 236 (%88,40) gebede depresyon alt ölçeği 7 ve üzerinde saptandı. Sonuç: Çalışmamızda GDM olan gebelerde anksiyete skoru ortalaması GDM olmayanlara göre anlamlı yüksek saptanmış olup depresyon düzeyi açısından iki grup arasında fark tespit edilmemiştir. Her ne kadar gebelikte ortaya çıkan diyabetin anksiyeteye neden olup olmadığı konusunda daha kapsamlı çalışmalar gerekse de, bu çalışma gestasyonel diyabetin antenatal anksiyete skorunda artışa neden olabileceğini düşündürtmektedir.